Literature DB >> 10761795

Women's regrets after bilateral prophylactic mastectomy.

D K Payne1, C Biggs, K N Tran, P I Borgen, M J Massie.   

Abstract

BACKGROUND: Primary prevention strategies such as chemopreventive agents (e.g., tamoxifen) and bilateral prophylactic mastectomy (PM) have received increasingly more attention as management options for women at high risk of developing breast cancer.
METHODS: A total of 370 women, who had registered in the Memorial Sloan-Kettering Cancer Center National Prophylactic Mastectomy Registry, reported having undergone a bilateral PM. Twenty-one of these women expressed regrets about their decision to have a PM. A psychiatrist and psychologist interviewed 19 of the women about their experiences with the PM.
RESULTS: A physician-initiated rather than patient-initiated discussion about the PM represented the most common factor in these women. Psychological distress and the unavailability of psychological and rehabilitative support throughout the process were the most commonly reported regrets. Additional regrets about the PM related to cosmesis, perceived difficulty of detecting breast cancer in the remaining breast tissue, surgical complications, residual pain, lack of education about the procedure, concerns about consequent body image, and sexual dysfunction.
CONCLUSIONS: Although a PM statistically reduces the chances of a woman developing breast cancer, the possibility of significant physical and psychological sequelae remains. Careful evaluation, education, and support both before and after the procedure will potentially reduce the level of distress and dissatisfaction in these women. We discuss recommendations for the appropriate surgical and psychiatric evaluation of women who are considering a PM as risk-reducing surgery.

Entities:  

Mesh:

Year:  2000        PMID: 10761795     DOI: 10.1007/s10434-000-0150-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

Review 1.  Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer.

Authors:  J R J De Leeuw; M J van Vliet; M G E M Ausems
Journal:  Fam Cancer       Date:  2008-03-14       Impact factor: 2.375

2.  Heightened perception of breast cancer risk in young women at risk of familial breast cancer.

Authors:  Rachael Glassey; Moira O'Connor; Angela Ives; Christobel Saunders; Sarah O'Sullivan; Sarah J Hardcastle
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

3.  Can self-esteem, mastery and perceived stigma predict long-term adjustment in women carrying a BRCA1/2-mutation? Evidence from a multi-center study.

Authors:  Andrea Vodermaier; Mary Jane Esplen; Christine Maheu
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

4.  Living my family's story: identifying the lived experience in healthy women at risk for hereditary breast cancer.

Authors:  Meghan L Underhill; Robin M Lally; Marc T Kiviniemi; Christine Murekeyisoni; Suzanne S Dickerson
Journal:  Cancer Nurs       Date:  2012 Nov-Dec       Impact factor: 2.592

5.  The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication.

Authors:  Robert Klitzman; Wendy Chung
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

6.  Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes.

Authors:  Rachel N Cusatis; Heather R Tecca; Anita D'Souza; Bronwen E Shaw; Kathryn E Flynn
Journal:  Cancer       Date:  2020-03-10       Impact factor: 6.860

7.  Preventive mastectomy in patients at breast cancer risk due to genetic alterations in the BRCA1 and BRCA2 gene.

Authors:  Susanne Taucher; Michael Gnant; Raimund Jakesz
Journal:  Langenbecks Arch Surg       Date:  2003-02-21       Impact factor: 3.445

8.  Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer.

Authors:  Louise Heiniger; Phyllis N Butow; Joseph Coll; Tracey Bullen; Judy Wilson; Brandi Baylock; Bettina Meiser; Melanie A Price
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

Review 9.  Persistent Post-Mastectomy Pain: Risk Factors and Current Approaches to Treatment.

Authors:  Raymond C Tait; Kim Zoberi; McKenzie Ferguson; Kimberly Levenhagen; Rebecca A Luebbert; Kevin Rowland; Gretchen B Salsich; Christopher Herndon
Journal:  J Pain       Date:  2018-06-30       Impact factor: 5.820

10.  A model for individualized risk prediction of contralateral breast cancer.

Authors:  Marzana Chowdhury; David Euhus; Tracy Onega; Swati Biswas; Pankaj K Choudhary
Journal:  Breast Cancer Res Treat       Date:  2016-11-04       Impact factor: 4.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.